Literature DB >> 7726225

Clinical and hematologic aspects of the X-linked alpha-thalassemia/mental retardation syndrome (ATR-X).

R J Gibbons1, L Brueton, V J Buckle, J Burn, J Clayton-Smith, B C Davison, R J Gardner, T Homfray, L Kearney, H M Kingston.   

Abstract

The hallmarks of the X-linked alpha-thalassemia/mental retardation (ATR-X) syndrome are severe psychomotor retardation, minor facial anomalies, genital abnormalities, and an unusual form of alpha-thalassemia. The demonstration of HbH inclusions in red blood cells after incubation with brilliant cresyl blue confirms the diagnosis. We describe 15 previously unreported cases and analyse the phenotypic and hematologic findings in these subjects and compare them with previously published cases. This study demonstrates the consistency of the main characteristics of this syndrome and extends the phenotype. Developmental changes in phenotype, in particular the coarsening of the facial appearance, are illustrated. The hematologic findings are shown to vary widely; in some cases the manifestation of alpha-thalassemia may be subtle and missed without repeated examination.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7726225     DOI: 10.1002/ajmg.1320550309

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  27 in total

1.  A novel mutation in the putative DNA helicase XH2 is responsible for male-to-female sex reversal associated with an atypical form of the ATR-X syndrome.

Authors:  A Ion; L Telvi; J L Chaussain; F Galacteros; J Valayer; M Fellous; K McElreavey
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

2.  The ATRX-ADD domain binds to H3 tail peptides and reads the combined methylation state of K4 and K9.

Authors:  Arunkumar Dhayalan; Raluca Tamas; Ina Bock; Anna Tattermusch; Emilia Dimitrova; Srikanth Kudithipudi; Sergey Ragozin; Albert Jeltsch
Journal:  Hum Mol Genet       Date:  2011-03-18       Impact factor: 6.150

Review 3.  Transcriptional coregulators: emerging roles of SRC family of coactivators in disease pathology.

Authors:  Subhamoy Dasgupta; Bert W O'Malley
Journal:  J Mol Endocrinol       Date:  2014-07-14       Impact factor: 5.098

4.  Glial and neuronal functions of the Drosophila homolog of the human SWI/SNF gene ATR-X (DATR-X) and the jing zinc-finger gene specify the lateral positioning of longitudinal glia and axons.

Authors:  Xuetao Sun; Tatiana Morozova; Margaret Sonnenfeld
Journal:  Genetics       Date:  2006-04-28       Impact factor: 4.562

5.  Arch fingerprints, hypotonia, and areflexia associated with X linked mental retardation.

Authors:  R E Stevenson; B Häne; J F Arena; M May; L Lawrence; H A Lubs; C E Schwartz
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

6.  Evaluation of a mutation screening strategy for sporadic cases of ATR-X syndrome.

Authors:  L Villard; M C Bonino; F Abidi; A Ragusa; J Belougne; A M Lossi; L Seaver; J P Bonnefont; C Romano; M Fichera; D Lacombe; A Hanauer; N Philip; C Schwartz; M Fontés
Journal:  J Med Genet       Date:  1999-03       Impact factor: 6.318

7.  α-Thalassemia, mental retardation, and myelodysplastic syndrome.

Authors:  Richard J Gibbons
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

8.  Decreased expression of GRAF1/OPHN-1-L in the X-linked alpha thalassemia mental retardation syndrome.

Authors:  Vincenza Barresi; Angela Ragusa; Marco Fichera; Nicolò Musso; Lucia Castiglia; Giancarlo Rappazzo; Salvatore Travali; Teresa Mattina; Corrado Romano; Guido Cocchi; Daniele F Condorelli
Journal:  BMC Med Genomics       Date:  2010-07-06       Impact factor: 3.063

9.  Dyrk1A potentiates steroid hormone-induced transcription via the chromatin remodeling factor Arip4.

Authors:  Jan Hendrik Sitz; Marcel Tigges; Karsten Baumgärtel; Leonid G Khaspekov; Beat Lutz
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

10.  Loss of ATRX in chondrocytes has minimal effects on skeletal development.

Authors:  Lauren A Solomon; Jennifer R Li; Nathalie G Bérubé; Frank Beier
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.